These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
957 related items for PubMed ID: 15083174
1. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up. Olivier RI, van Beurden M, Lubsen MA, Rookus MA, Mooij TM, van de Vijver MJ, van't Veer LJ. Br J Cancer; 2004 Apr 19; 90(8):1492-7. PubMed ID: 15083174 [Abstract] [Full Text] [Related]
2. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations. Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT. Gynecol Oncol; 2005 May 19; 97(2):457-67. PubMed ID: 15863145 [Abstract] [Full Text] [Related]
3. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B, Murphy J, Ghadirian P, Friedman E, Foulkes WD, Kim-Sing C, Wagner T, Tung N, Couch F, Stoppa-Lyonnet D, Ainsworth P, Daly M, Pasini B, Gershoni-Baruch R, Eng C, Olopade OI, McLennan J, Karlan B, Weitzel J, Sun P, Narod SA, Hereditary Ovarian Cancer Clinical Study Group. JAMA; 2006 Jul 12; 296(2):185-92. PubMed ID: 16835424 [Abstract] [Full Text] [Related]
4. Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation. Laki F, Kirova YM, This P, Plancher C, Asselain B, Sastre X, Stoppa-Lyonnet D, Salmon R, IC-BOCRSG IC-BOCRSG: Institut Curie - Breast Ovary Cancer Risk Study Group. Cancer; 2007 May 01; 109(9):1784-90. PubMed ID: 17351952 [Abstract] [Full Text] [Related]
5. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K. N Engl J Med; 2002 May 23; 346(21):1609-15. PubMed ID: 12023992 [Abstract] [Full Text] [Related]
6. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL, Prevention and Observation of Surgical End Points Study Group. N Engl J Med; 2002 May 23; 346(21):1616-22. PubMed ID: 12023993 [Abstract] [Full Text] [Related]
7. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Finch A, Shaw P, Rosen B, Murphy J, Narod SA, Colgan TJ. Gynecol Oncol; 2006 Jan 23; 100(1):58-64. PubMed ID: 16137750 [Abstract] [Full Text] [Related]
8. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. Manchanda R, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, Burnell M, Side L, Gessler S, Saridogan E, Oram D, Jacobs I, Menon U. BJOG; 2011 Jun 23; 118(7):814-24. PubMed ID: 21392246 [Abstract] [Full Text] [Related]
9. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy. Lamb JD, Garcia RL, Goff BA, Paley PJ, Swisher EM. Am J Obstet Gynecol; 2006 Jun 23; 194(6):1702-9. PubMed ID: 16731090 [Abstract] [Full Text] [Related]
10. Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers. Rhiem K, Foth D, Wappenschmidt B, Gevensleben H, Büttner R, Ulrich U, Schmutzler RK. Arch Gynecol Obstet; 2011 Mar 23; 283(3):623-7. PubMed ID: 20428881 [Abstract] [Full Text] [Related]
11. Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens. Reitsma W, de Bock GH, Oosterwijk JC, Bart J, Hollema H, Mourits MJ. Eur J Cancer; 2013 Jan 23; 49(1):132-41. PubMed ID: 22921157 [Abstract] [Full Text] [Related]
12. Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature. Carcangiu ML, Peissel B, Pasini B, Spatti G, Radice P, Manoukian S. Am J Surg Pathol; 2006 Oct 23; 30(10):1222-30. PubMed ID: 17001151 [Abstract] [Full Text] [Related]
13. Additional salpingectomy after previous prophylactic oophorectomy in high-risk women: sense or nonsense? Olivier RI, Lubsen-Brandsma LA, van Boven H, van Beurden M. Gynecol Oncol; 2005 Feb 23; 96(2):439-43. PubMed ID: 15661233 [Abstract] [Full Text] [Related]
15. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations. Casey MJ, Bewtra C. Fam Cancer; 2004 Feb 23; 3(3-4):265-81. PubMed ID: 15516851 [Abstract] [Full Text] [Related]
16. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations. Schmeler KM, Sun CC, Bodurka DC, White KG, Soliman PT, Uyei AR, Erlichman JL, Arun BK, Daniels MS, Rimes SA, Peterson SK, Slomovitz BM, Milam MR, Gershenson DM, Lu KH. Obstet Gynecol; 2006 Sep 23; 108(3 Pt 1):515-20. PubMed ID: 16946209 [Abstract] [Full Text] [Related]
17. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Finch A, Metcalfe KA, Chiang JK, Elit L, McLaughlin J, Springate C, Demsky R, Murphy J, Rosen B, Narod SA. Gynecol Oncol; 2011 Apr 23; 121(1):163-8. PubMed ID: 21216453 [Abstract] [Full Text] [Related]